Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

Summary

Phase II trial to study the effectiveness of romidepsin in treating patients who have locally advanced or metastatic neuroendocrine tumors. Drugs used in chemotherapy, such as romidepsin, work in different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start

2004-03

Primary completion

2004-10

Completion

—

Drugs

Indications